GTS Securities LLC Lowers Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

GTS Securities LLC lessened its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 89.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 16,197 shares of the pharmacy operator's stock after selling 144,796 shares during the quarter. GTS Securities LLC's holdings in Walgreens Boots Alliance were worth $151,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Golden State Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth about $26,000. Riverview Trust Co lifted its holdings in Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after buying an additional 1,590 shares during the period. Colonial Trust Co SC grew its position in shares of Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after buying an additional 1,297 shares during the last quarter. Venturi Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $28,000. Finally, Independence Bank of Kentucky purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $39,000. Institutional investors own 58.59% of the company's stock.

Insider Transactions at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina acquired 832,258 shares of the business's stock in a transaction dated Sunday, April 27th. The stock was purchased at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the transaction, the chairman now directly owns 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. The trade was a 0.57% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 17.50% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Wall Street Zen assumed coverage on Walgreens Boots Alliance in a research note on Wednesday, May 21st. They issued a "hold" rating for the company. Wolfe Research raised Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Finally, Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a "hold" rating to a "sell" rating and dropped their price target for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Stock Performance

WBA traded up $0.05 during mid-day trading on Tuesday, reaching $11.25. 2,904,197 shares of the company traded hands, compared to its average volume of 20,881,256. The company's fifty day moving average price is $11.03 and its 200-day moving average price is $10.52. The stock has a market capitalization of $9.73 billion, a P/E ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.77. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $16.27.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $38.59 billion during the quarter, compared to analysts' expectations of $37.90 billion. During the same quarter in the prior year, the business earned $1.20 earnings per share. Walgreens Boots Alliance's revenue for the quarter was up 4.1% compared to the same quarter last year. On average, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.